This Month in Psychopharmacology

THIS MONTH IN
PSYCHOPHARMACOLOGY

Browsing articles in "Sleep"

Stabilizing Circadian Rhythm Tied To Lower Suicide Risk In Bipolar Disorder
January 21, 2022

Circadian rhythm instabilities are associated with bipolar symptom severity and increased suicide risk. In a recent study, a 12-week social rhythm therapy, delivered predominantly via telehealth was tested in adolescents and young adults with bipolar disorder. The primary goal was to...

Continue reading (Members only)

FDA Approves New Drug For Insomnia
January 10, 2022

A U.S. Food and Drug Administration has approveda new drug for the treatment of adult patients with insomnia.....

Continue reading (Members only)

FDA-Approved First Treatment for Idiopathic Hypersomnia
September 16, 2021

The US Food and Drug Administration (FDA) has just approved the first treatment for adult idiopathic hypersomnia, a condition in which patients experience chronic excessive daytime sleepiness, sleep inertia, prolonged yet non-restorative nighttime sleep and naps, and cognitive impairment...

Benefits of ECT May Outweigh Risks for Patients Hospitalized for Depression
August 6, 2021

There have been confounding results from previous studies that assess the risk of medical complications from electroconvulsive therapy (ECT) and this may contribute to the lack of use for this therapeutic treatment. In a recent retrospective cohort study serious medical events associated with ECT were examined...

Continue reading (Members only)

Patients With Social Anxiety Disorder Treated for Sleep Problems May Have Better Outcomes
June 15, 2021

Social anxiety disorder is associated with sleep disturbance, which may, in turn, interfere with learning and memory processes that are integral for exposure therapy. A recent study tested the relationships between exposure therapy outcomes and sleep disturbances both at baseline and before and after exposure-based therapy sessions in...

Short Sleep Tied to Increased Dementia Risk
May 4, 2021

In a recent study, the association between sleep dysregulation and dementia was examined. Data from 7,959 participants of the Whitehall II study was analyzed for sleep duration and the incidence of dementia, using a 25-year follow-up. A total of...

Continue reading (Members only)

Disturbed Sleep and Depression in Children and Youths
April 9, 2021

In a recently published meta-analysis, the relationship between disturbed sleep and depression was examined. A total of 22 studies were included in the study, of which 16 were included in the meta-analysis. Disturbed sleep was...

Continue reading (Members only)

FDA Authorizes Marketing For Daytime Treatment For Obstructive Sleep Apnea
February 28, 2021

The U.S. Food and Drug Administration has approved the first daytime electrical stimulation device for the treatment of obstructive sleep apnea. The device strengthens tongue muscles through electrical stimulation, and...

Continue reading (Members only)

Histamine 3 Receptor Inverse Agonist For Cognitive Disorders
February 26, 2021

istamine H3 receptors, found throughout the cortex and hippocampus, have been hypothesized to be involved with cognition, learning, and memory. Several preclinical animal model studies have shown that H3 receptor antagonists/inverse agonists may have procognitive effects; however...

Continue reading (Members only)

FDA Approves PTSD Sleep Device for Nightmares
November 11, 2020

The U.S. Food and Drug Administration granted marketing authorization of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder...

Top of Page